Early Prediction of Nonprogression in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib By Using [18F]Fluorodeoxyglucose and [18F]Fluorothymidine Positron Emission Tomography

Positron emission tomography (PET) with both 2'-deoxy-2'-[(18)F]fluoro-D-glucose (FDG) and 3'-[(18)F]fluoro-3'-deoxy-L-thymidine (FLT) was evaluated with respect to the accuracy of early prediction of nonprogression following erlotinib therapy, independent from epidermal growth f...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2011-05, Vol.29 (13), p.1701-1708
Hauptverfasser:	Zander, Thomas, Scheffler, Matthias, Nogova, Lucia, Kobe, Carsten, Engel-Riedel, Walburga, Hellmich, Martin, Papachristou, Irini, Toepelt, Karin, Draube, Andreas, Heukamp, Lukas, Buettner, Reinhard, Ko, Yon D, Ullrich, Roland T, Smit, Egbert, Boellaard, Ronald, Lammertsma, Adriaan A, Hallek, Michael, Jacobs, Andreas H, Schlesinger, Andreas, Schulte, Karin, Querings, Silvia, Stoelben, Erich, Neumaier, Bernd, Thomas, Roman K, Dietlein, Markus, Wolf, Jürgen
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Carcinoma, Non-Small-Cell Lung - diagnosis Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - mortality Dideoxynucleosides Disease-Free Survival Erlotinib Hydrochloride Female Fluorodeoxyglucose F18 Genes, erbB-1 Humans Lung Neoplasms - diagnosis Lung Neoplasms - drug therapy Male Middle Aged Mutation Positron-Emission Tomography - methods Prognosis Quinazolines - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!